Physician profile
Michael Koslow
NPI 1295714749
$2,113.38
in general payments reported to CMS, 2019-2025
24 companies · $46.28 in 2025
The $46.28 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $438 · 2020: $152 · 2021: $379 · 2022: $337 · 2023: $631 · 2024: $131 · 2025: $46.28.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $808.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $807.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $384.83 | 2021-2023 | |
| Pfizer INC. | $367.01 | 2019-2024 | |
| E.R. Squibb & Sons, L.L.C. | $238.53 | 2019-2024 | Camzyos, Eliquis |
| W. L. Gore & Associates, INC. | $164.37 | 2019-2021 | |
| Impulse Dynamics (USA) INC. | $139.88 | 2023-2025 | Optimizer, Optimizer |
| Janssen Pharmaceuticals, INC | $107.58 | 2019-2021 | |
| Shockwave Medical, INC | $94.39 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Sanofi-Aventis U.S. LLC | $69.69 | 2019-2020 | |
| Cardinal Health 200 LLC | $66.35 | 2019-2020 | |
| Atricure, INC. | $59.00 | 2022 | |
| Philips North America LLC | $58.93 | 2019-2021 | |
| Abiomed | $45.81 | 2022 | |
| Novartis Pharmaceuticals Corporation | $45.77 | 2019-2022 | |
| Medtronic, INC. | $40.00 | 2023 | Onyx Frontier |
| Amgen INC. | $39.00 | 2019-2020 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $33.41 | 2019 | |
| Edwards Lifesciences Corporation | $27.46 | 2021 | |
| Cordis US Corp. | $27.09 | 2025 | |
| Medtronic Vascular, INC. | $24.12 | 2020 | |
| Cardiovascular Systems INC. | $19.36 | 2021 | |
| Biotronik INC. | $17.88 | 2020 | |
| Astellas Pharma US INC | $17.13 | 2019 | |
| Siemens Medical Solutions USA, INC. | $14.40 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $11.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Koslow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.